Results
1 -
7 of
7Aston Nicola M., Bamborough Paul, Buckton Jacqueline B., Edwards Christopher D., Holmes Duncan S., Jones Katherine L., Patel Vipulkumar K., Smee Penny A., Somers Donald O., Vitulli Giovanni, Walker Ann L..
p38α Mitogen-Activated Protein Kinase Inhibitors: Optimization of a Series of Biphenylamides to Give a Molecule Suitable for Clinical Progression, Journal of Medicinal Chemistry, 2009 Cooling down inflammation in type 2 diabetes: how strong is the evidence for cardiometabolic benefit?, Endocrine Losmapimod concentrationu2013QT relationship in healthy volunteers: meta-analysis of data from six clinical trials, European Journal of Clinical Pharmacology Population Pharmacokinetics of Losmapimod in Healthy Subjects and Patients with Rheumatoid Arthritis and Chronic Obstructive Pulmonary Diseases, Clinical Pharmacokinetics Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease, American Journal of Cardiovascular Drugs Emerging Agents for the Management of Nephrotic Syndrome: Progress to Date, Pediatric Drugs Comparison of analysis approaches for multi-level vascular imaging data, Trials